Servier targeted by fresh claims from UK health authorities
( July 24, 2026, 13:34 GMT | Official Statement) -- MLex Summary: Servier Laboratories has been targeted by fresh claims from UK health authorities over alleged anticompetitive agreements for the blood pressure medication perindopril, according to filings with the Competition Appeal Tribunal. The CAT said the claims duplicated ongoing litigation over the same matters in the UK courts, but the new actions respond to challenges that proceedings are out of time. Summary of claims attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.